Related Experiment Video
Updated: Apr 14, 2026
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Curcumin: Promising Modulator of Hypoxia Signaling in Cancer
Tejveer Singh1, Deepika Sharma1, Shubham Adhikari2
1Translational Oncology Laboratory, Department of Zoology, Hansraj College, Delhi University, New Delhi, India.
Abstract:
Solid tumors are widely known for having hypoxia, which promotes the growth and metastasis of the tumor. It is crucial for research and medicine to comprehend the diverse strategies by which cells sense oxygen and preserve oxygen homeostasis. A rising number of drugs have been found to block hypoxia function through various molecular pathways. For instance, curcumin, a naturally occurring polyphenolic chemical, has the ability to alter the tumor microenvironment and significantly influence the course of malignancy. Studies revealed that curcumin inhibits the signaling pathways including PI3K/Akt, AMPK-mTOR, and NF-κB, which are key factors in preventing hypoxia-induced cancer spread. In this article, we have discussed about the potential use of curcumin as a promising inhibitor of the molecular targets essential for hypoxia cell survival. Therefore, curcumin with strong anticancer effects could work well as a tumor-static drug in chemoprevention by inactivating hypoxia.
Insights
Curcumin, a natural compound, effectively inhibits cancer cell growth and spread by targeting hypoxia pathways. This research highlights curcumin
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Solid tumors frequently exhibit hypoxia, a condition that fuels tumor progression and metastasis.
- Understanding cellular oxygen sensing and homeostasis is vital for cancer research and treatment.
- Targeting hypoxia-inducible pathways presents a promising therapeutic strategy in oncology.
Purpose of the Study:
- To explore the potential of curcumin as an inhibitor of molecular targets crucial for hypoxia-induced cancer cell survival.
- To elucidate the role of curcumin in modulating the tumor microenvironment and its impact on malignancy.
Main Methods:
- Review of existing studies on curcumin's effects on cancer signaling pathways.
- Analysis of curcumin's inhibitory action on key molecular targets involved in hypoxia.
- Investigation of curcumin's influence on hypoxia-driven cancer cell proliferation and metastasis.
Main Results:
- Curcumin demonstrated significant inhibition of critical signaling pathways, including PI3K/Akt, AMPK-mTOR, and NF-κB.
- These pathways are integral to preventing the spread of hypoxia-induced cancers.
- Curcumin alters the tumor microenvironment, impacting the course of malignancy.
Conclusions:
- Curcumin shows promise as a chemopreventive agent by inactivating hypoxia.
- Its ability to inhibit key molecular targets essential for cancer cell survival underscores its potential as a tumor-static drug.
- Further research into curcumin's anticancer effects is warranted.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:24Regulation of Angiogenesis and Blood Supply
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
01:23Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...